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Abstract
Background: Obesity, particularly morbid obesity, has various physical and mental complications. Excessive daytime somnolence
(EDS) is a sleep disorder that reduces individuals’ performance capability and the accuracy of their short-term memory and causes
learning problems. This retrospective study aimed to document the presence of EDS in a sample of obese patients in comparison to
patients with a normal weight.
Objectives: This article compares the excessive daytime sleepiness of obese and non-obese patients in the minimally invasive
surgery research center in Tehran, Iran.
Patients andMethods: In this case-control study, we compared excessive daytime sleepiness in 55 obese patients who were candi-
dates for laparoscopic surgery, with a body mass index (BMI) of equal to or greater than 30 kg/ m2, with 55 controls with a normal
BMI (19.5 - 24.9 kg/ m2). The process of selecting the control group in our case-control study is matching in group levels, so that the
controls are similar to the case group with regard to certain key characteristics, such as age, sex, and race. The sleep assessment
was based on the Epworth sleepiness scale (ESS) questionnaire. Analysis of variance (ANOVA) was used to compare the means of
quantitative data, such as the ESS score of groups.
Results: Sleepiness was not affected by gender in cases or controls. The sleepiness prevalence was 29 (52.7%) in the cases group and
17 (30.9%) in the control group (OR = 2.493 (95% CI 1.144 -5.435)). The mean ESS scores in cases and controls were 7.82 ± 3.86 and
10.54± 6.15, respectively (P = 0.007). Moreover, the prevalence of sleepiness and the mean ESS scores in class III of obesity differed
significantly from the controls (16 (57.1%) vs. 17 (30.9%)) (OR = 2.980 (95% CI 1.162 - 7.645)) and (11.04± 5.93 vs. 7.82± 3.86) (P = 0.013),
respectively.
Conclusions: Our findings suggest a strong relationship between EDS and obesity, particularly morbid obesity. Therefore, physi-
cians must be familiar with EDS as a mixed clinical entity indicating careful assessment and specific treatment planning.
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1. Background
The prevalence of obesity has been increasing over the
past few centuries (1). Obesity, and specifically morbid
obesity, has various medical complications such as dia-
betes, hypertension, nonalcoholic steato-hepatitis, hyper-
lipidemia, polycystic ovary syndrome (PCOS), thrombotic
problems, and menstrual irregularity (2-4).
In addition to medical problems, obesity is associated
with numerous psychiatric complications, such as neu-
rocognitive disturbances, mood disorders, anxiety disor-
ders, eating disorders and sleeping disorders (5-10).
Excessive daytime sleepiness (EDS) is a frequent com-
plaint in obese patients. EDS affects around 20% of the
normal population and reduces individuals’ performance
capability and the accuracy of their short-term memory.
Additionally, it causes learning problems and hazardous
events, such as car accidents (11, 12).
There is still controversy regarding the etiology of
sleepiness. Some studies have suggested that it might
be due to the medications’ pharmacological effects and
might have serious consequences related to patients’ fa-
tigue (13, 14). Other researchers have suggested that re-
duced hippocampal volume is a risk factor for EDS (15). Re-
garding the association of sleepiness with obesity, some re-
searchers have proposed that EDS is also independently re-
lated to anxiety or depression, and some have suggested
that obesity is an independent predictor of sleepiness in
this population (16, 17). The reduction in neuro-endocrine
factors levels, such as leptin, in obese patients is also sug-
gested as a reason for the changes in sleep quality in obese
patients (18).
Previous studies have shown that regular meal pat-
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terns in adults and breast feeding in children are impor-
tant factors for preventing metabolic syndrome criteria in
childhood and later years of life (19). In obese patients,
the severity of obesity, excessive fat intake, and a higher
BMI were associated with a higher prevalence of excessive
sleepiness (9, 19-23).
Obesity causes sleep disturbances by affecting ventila-
tion, increasing airway obstructions, and causing critical
pressure, which leads to daytime hypercapnia. Daytime
sleepiness is associated with mechanical traumas during
activities such as driving and working (7, 24).
2. Objectives
The earlier relevant studies were performed on non-
obese cases. In contrast, we have evaluated EDS in obese
and specifically morbidly obese patients. Moreover, we
have compared them to the case group to evaluate the
prevalence of the EDS in these patients. In addition, no sim-
ilar studies have been done on morbidly obese patients in
Iran. Our study focused on morbidly obese patients.
3. Patients andMethods
In this case-control study, we compared excessive day-
time sleepiness in 55 obese and morbidly obese patients
who were candidates for laparoscopic surgery, in the mini-
mally invasive surgery research center in Tehran, Iran with
55 controls of normal weight (BMI: 19.5 - 24.9 kg/ m2). Obe-
sity was defined as a body mass index (BMI) ≥ 30 kg/ m2
and patients were categorized into three groups according
to their BMI: 30 - 34.9 = class I, 35 - 39.9 = class II, and BMI
≥ 40 = class III or morbidly obese. Normal weight was de-
fined as a BMI of 19.5 - 24.9 kg/ m2 (25).
The sample size was calculated using The G × Power
software with the use of the following sample size (For-
mula 1):
(1)
2× (z1−α + z1−β)2 × σ2
d2
The process of selecting the control group in our case-
control study is matching in group levels. In other words,
participants in the case group are not matched to the con-
trol group individually; instead, they are matched at the
group level. The control group is similar to the case group
with regard to certain key characteristics, such as age, sex,
and race. Among 68 patients who entered into our study,
11 patients had a history of using sedative drugs, such as
benzodiazepines and other psychiatric medications, and 2
patients who had hypothyroidism were excluded from the
study. Demographic data, including age, sex, BMI, and du-
ration of obesity, were collected through a questionnaire.
The sleep assessment was based on the 8-item Epworth
sleepiness scale (ESS) questionnaire, which has been de-
signed to determine a subject’s likelihood to doze off or fall
asleep in different situations. Reponses to each item are
ranked from 0 to 3 according to the probability of dozing
off during a task (0 = never, 1 = low probability, 2 = mod-
erate probability, 3 = high probability), which results in a
total score of 24 for the questionnaire; a score of 0 - 9 was
categorized as normal, 10 - 15 intermediate, and≥ 16 as a
symptom of severe sleep disorders (11). The Iranian version
of the ESS is a reliable and valid measure for evaluating day-
time sleepiness. Its reliability for use with students was re-
ported as being over 0.70 in Masoudzade’s and Sadeghni-
iat’s studies (26, 27).
Statistical analysis was performed with SPSS 11.5 for
Windows. Analysis of the data distribution was assessed
by the Kolmogorov-Smirnov test for normally distributed
data. To determine whether the variances of data in groups
were equal, the Leven test was used. The chi-square or
Fisher’s exact test was used to compare the qualitative data
and prevalence of sleepiness in all three groups. Analysis
of variance (ANOVA) was used to compare the means of
quantitative data, such as age and the ESS scores of BMI
groups. To evaluate the odds of sleep disturbances in the
case group, logistic regression analysis was used; there-
fore, odds ratios (ORs) and 95% confidence intervals (95%
CIs) were calculated. The quantitative data were expressed
as mean ± standard deviation (SD); in contrast, for the
qualitative data, frequencies (percentages) were used. A P
value of less than 0.05 indicated statistical significance.
4. Results
We recruited 55 obese patients in the case group with
a mean age of 39.47± 10.61 years and a mean BMI of 40.32
± 7.47 kg/m2 and 55 non-obese controls with a mean age of
38.94± 10.66 and a mean BMI of 23.10± 1.32.
Forty-four patients (80%) in the obese group and 40 pa-
tients (72.7%) in the control group were married. Forty-five
patients (83.3%) in the obese group and 49 patients (89.1%)
in the control group were women. Both groups were com-
pared according to mean age (P = 0.795), gender (P = 0.383),
and marital status (P = 0.369); the data are shown in Table
1.
Sleepiness was not affected by gender in the case or
control group. The prevalence of sleepiness in females and
males was 23 (51.1%) versus 6 (66.7%)) (P = 0.480) in the case
group and 15 (30.6%) versus 2 (33.3%)) (P = 0.892) in the con-
trol group. Therefore, no significant difference was found.
The prevalence of sleepiness in the case group was 29
(52.7%) and in the control group was 17 (30.9%) (OR = 2.493
(95% CI 1.144 - 5.435)). In addition, the mean ESS scores in
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Table 1. Comparison of the Prevalence of Sleep Disturbances in Cases and Controlsa
Variable Control, n = 55 Case Group, n = 55 OR (95 % CI)
30 - 34.9, n = 15 35 - 39.9, n = 12 ≥ 40, n = 28 Total
Age 38.94± 10.66 37.3± 12.17 43.83± 9.78 38.53± 9.91 39.47± 10.61 0.795
Sex 0.383
Female 49 (89.1) 12 (80) 9 (81.8) 24 (85.7) 45 (83.3)
Male 6 (10.9) 3 (20) 2 (18.2) 4 (14.3) 9 (16.7)
Marital status 0.369
Single 15 (27.3) 4 (26.7) 1 (8.3) 6 (21.4) 11 (20)
Married 40 (72.7) 11 (73.3) 11 (91.7) 22 (78.6) 44 (80)
Sleepiness OR = 2.493 (95% CI 1.144 - 5.435)c
No 37 (69.1) 9 (60) 5 (41.7) 12 (42.9)b 26 (47.3)b
Yes 17 (30.9) 6 (40) 7 (58.3) 16 (57.1) 29 (52.7)
ESS score 7.82± 3.86 8.67± 5.20 11.75± 7.62b 11.04± 5.93b 10.54± 6.14b OR = 2.980 (95% CI 1.162–7.645)b
aValues are expressed as No (%) or mean± SD.
cOR between case (without categorization) and control groups.
bCompared with the control group, P < 0.05.
the case and control groups were 7.82±3.86 and 10.54 ±
6.15. This difference between the two groups was statisti-
cally significant (P = 0.007).
Among the case group patients who reported sleepi-
ness, 15 (27.3%) had intermediate and 14 (25.5%) had severe
sleep disturbances. Alternatively, among the control group
patients who expressed sleepiness, 15 (27.3%) had interme-
diate and 2 (3.6%) had severe disturbances.
We found a significant association between BMI and
sleepiness in cases; their likelihood of reporting sleepiness
increased significantly as their BMI increased (OR = 1.01
(95% CI 1.01 - 1.20)).
We divided cases into three groups based on patients’
BMI: 30 - 34.9 = class I, 35 - 39.9 = class II, and≥ 40 = class
III of obesity (23); patients did not differ between the three
BMI categories in respect to their mean age (P = 0.270), gen-
der (P = 0.881), marital status (P = 0.476), sleepiness (P =
0.510), and their mean ESS score (P = 0.368) (Table 2). Com-
paring these results, we noted that neither sleep distur-
bances nor ESS scores were statistically significantly differ-
ent between the three groups of obesity.
There was no significant difference between class I obe-
sity and the control group in respect to their prevalence of
sleepiness (6 (40%) vs. 17 (30.9%)) (P = 0.545) and mean ESS
scores (8.67 ± 5.20 vs. 7.82 ± 3.86) (P = 0.487).We found a
similar result for class II obese patients in their prevalence
of sleepiness, (7 (58.3%) vs. 17 (30.9%)) (P = 0.510); the mean
ESS scores of this obesity class and the control group signif-
icantly differed (11.75± 7.62 vs. 7.82± 3.86) (P = 0.011).
However, the prevalence of sleepiness and the mean
ESS scores statistically significantly differed for class III
obese patients and the control group, respectively (16
(57.1%) vs. 17 (30.9%)) (OR = 2.980 (95% CI 1.162 - 7.645)) and
(11.04± 5.93 vs. 7.82± 3.86) (P = 0.013).
5. Discussion
The prevalence of sleepiness was 29 (52.7%) in the case
group and 17 (30.9%) in the control group. The mean ESS
scores in the case group and the control group were 7.82±
3.86 and 10.54 ± 6.15, respectively (P = 0.007). The preva-
lence of EDS in patients with obesity has been reported
to range from 4% to 31% in earlier studies (12, 28-30). In
this study, a high prevalence of EDS was revealed among
obese patients, consistent with several prior studies. Roth
T’s study showed a higher prevalence of sleep disorders in
obese patients (23, 24, 28, 31). Dixon showed that an aver-
age weight loss of 48% after bariatric surgery (SD = 16%) re-
duced the prevalence of daytime sleepiness (from 39% pre-
operation to 4% post-operation (P = 0.001) (24). In another
study by Krieger et al. (31) AC, 12 months after bariatric
surgery, patients’ mean excess weight loss was 44.4± 14%
and the apnea-hypopnea index decreased from 34.2 ± 35
to 19.0 ± 21.7 events per hour (P < 0.0001). In Mendes et
al. study, daytime excessive sleepiness was one of the most
common symptoms in OSA, and the distribution of OSA ac-
cording to weight was as follows: 7% had normal weight, 2%
were overweight (BMI 25 - 30), 37% grade I obesity (BMI 25.1
- 30); 9% grade II obesity (BMI 30.1 - 35), and grade III obesity
(BMI greater than 35) in 45% of cases (32).
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Table 2. Comparison of the Prevalence of Sleep Disturbances in Three Classes of Obesitya
Variable BMI P Value
30 - 34.9, n = 15 35 - 39.9, n = 12 ≥ 40, n = 28
Age 37.3± 12.17 43.83±9.78 38.53± 9.91 0.270
Sex
Female 12 (80) 9 (81.8) 24 (85.7) 0.881
Male 3 (20) 2 (18.2) 4 (14.3)
Marital status
Single 4 (26.7) 1 (8.3) 6 (21.4) 0.476
Married 11 (73.3) 11 (91.7) 22 (78.6)
Sleepiness
No 9 (60) 5 (41.7) 12 (42.9) 0.510
Yes 6 (40) 7 (58.3) 16 (57.1)
ESS score 8.67± 5.20 11.75± 7.62 11.04± 5.93 0.368
aValues are expressed as No (%) or mean± SD.
Noticeably, there is no significant association between
obesity and sleep breathing disorder, according to Esteller-
More et al.’s study (33) and the prevalence of daytime
sleepiness is 22.3% versus 23.8% in children with and with-
out sleep breathing disorder, respectively. In addition,
Palm found no independent association between the BMI
level at baseline and the development of new sleep prob-
lems (34).
Moreover, we demonstrated that the differences in
the prevalence of sleepiness and the mean ESS scores in
class III obesity and controls were statistically significant
(P = 0.013). This means that morbidly obese patients have
higher ESS scores and a higher risk of severe daytime sleepi-
ness, which was not highlighted in earlier studies.
In our study, similar to an earlier study (35), the case
and control groups did not differ in terms of their mean
age (P = 0.270), gender (P = 0.881), and marital status (P =
0.476); in contrast, other studies have shown gender differ-
ences in the prevalence of daytime sleepiness (36). In addi-
tion, several studies, including a cross-sectional survey by
Kachikis et al. (37), have reported several socioeconomic
factors including age, education, marital status, and em-
ployment status associated with sleep characteristics such
as short sleep and inadequate sleep.
Several studies have demonstrated a strong correla-
tion between daytime sleepiness and obstructive sleep ap-
nea (OSA) (38). The Canadian public health agency has also
reported the prevalence of self-reported OSA in 2009 (39).
These findings highlight the need for studies investigating
the effectiveness of the ESS as a screening tool to measure
OSA. Although not assessing OSA might be a limitation of
our study, polysomnography is not a practical screening
method, as it requires 24-hour hospitalization.
Our findings suggest a strong relationship between
EDS and obesity, specifically morbid obesity. This study
showed that morbidly obese patients have higher ESS
scores and a higher risk of severe daytime sleepiness.
Therefore, physicians need to be familiar with EDS as a
mixed clinical entity that indicates careful assessment and
specific treatment planning. Different methods such as
dietary modifications in obese patients and surgical pro-
cedures in morbidly obese patients result in less EDS and
fewer sleep disturbances.
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